VYJUVEK
Drug
Krystal Biotech Inc
Total Payments
$1.2M
Transactions
1,935
Doctors
1,323
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $135,095 | 1,110 | 801 |
| 2023 | $1.1M | 825 | 610 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $955,050 | 17 | 80.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $152,850 | 56 | 12.9% |
| Food and Beverage | $61,984 | 1,766 | 5.2% |
| Travel and Lodging | $15,734 | 37 | 1.3% |
| Consulting Fee | $1,800 | 1 | 0.2% |
| Education | $911.76 | 58 | 0.1% |
Payments by Type
Research
$955,050
17 transactions
General
$233,280
1,918 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| OPEN LABEL TREATMENT OF BEREMAGENE GEPERPAVEC (B-VEC) | Krystal Biotech Inc | $955,050 | 0 |
Top Doctors Receiving Payments for VYJUVEK
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Emma Larson | — | Baltimore, MD | $955,546 | 22 |
| , MD | Pediatric Dermatology | San Antonio, TX | $37,388 | 49 |
| , M.D | Pediatric Dermatology | Miami Beach, FL | $32,974 | 30 |
| , M.D | Pediatrics | Charleston, SC | $32,791 | 33 |
| , MD | Dermatology | Stanford, CA | $32,007 | 17 |
| , MD | Dermatology | San Clemente, CA | $19,052 | 17 |
| , MD | Pediatric Dermatology | Wexford, PA | $12,936 | 16 |
| , M.D | Pediatric Dermatology | Detroit, MI | $4,239 | 11 |
| , FRCOPHTH | Ophthalmology | Pittsburgh, PA | $1,800 | 1 |
| , MD | Dermatology | Milwaukee, WI | $800.00 | 2 |
| , APRN-CNP | Family | Cincinnati, OH | $390.09 | 10 |
| , CNP | Nurse Practitioner | Cincinnati, OH | $355.45 | 9 |
| , M.D | Dermatology | Edmond, OK | $290.58 | 10 |
| , PA-C | Physician Assistant | Edmond, OK | $277.68 | 9 |
| Akshitha Thatiparthi | Student in an Organized Health Care Education/Training Program | Loma Linda, CA | $242.54 | 2 |
| , MD | Dermatology | Boston, MA | $236.11 | 2 |
| , NP | Dermatology | Boston, MA | $236.11 | 2 |
| , MD | Dermatology | Austin, TX | $227.64 | 14 |
| , MD | Dermatology | Grapevine, TX | $224.12 | 11 |
| , PA-C | Physician Assistant | Wildomar, CA | $221.22 | 5 |
| Austinn Miller | Dermatology | Tallahassee, FL | $213.57 | 3 |
| , M.D | Pediatric Dermatology | Fairfax, VA | $197.21 | 5 |
| , PA-C | Medical | San Antonio, TX | $194.04 | 10 |
| , PA-C | Medical | San Antonio, TX | $186.26 | 4 |
| , DO | Pediatric Dermatology | Cincinnati, OH | $185.51 | 5 |
Ad
Manufacturing Companies
- Krystal Biotech Inc $1.2M
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 1,323
- Transactions 1,935
About VYJUVEK
VYJUVEK is a drug associated with $1.2M in payments to 1,323 healthcare providers, recorded across 1,935 transactions in the CMS Open Payments database. The primary manufacturer is Krystal Biotech Inc.
Payment data is available from 2023 to 2024. In 2024, $135,095 was paid across 1,110 transactions to 801 doctors.
The most common payment nature for VYJUVEK is "Unspecified" ($955,050, 80.4% of total).
VYJUVEK is associated with 1 research study, including "OPEN LABEL TREATMENT OF BEREMAGENE GEPERPAVEC (B-VEC)" ($955,050).